← Feed

$DXCM

2 theses
bullish 50%neutral 50%bearish 0%
Avg return (6m)
—
Win rate (6m)
— (0 resolved)
1d3d1w1m3m6m1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 8, 4:30 PM ET
$DXCMr/ValueInvestingDiscussionneutral
u/Idntevncare · 33d ago8 prior · awaiting results

HEALTHCARE is a great value right now

Dexcom is mentioned as a comparison point for MMED valuation; author suggests MMED's revenue generation relative to DXCM's 31B market cap indicates potential mispricing in the biotech/medical device space.

At post $83.02Now $84.53+1.8% since postedas of Sep 8, 4:30 PM ET
original post →
$DXCMr/wallstreetbetsYOLObullish
u/EmptyCash5704 · 110d agono track record yet
“41K bet (image reference)”

41K bet on DXCM turnaround play

CGM technology mainstream adoption, revenue growth acceleration, margin expansion, Stelo product success, and type 2 diabetes coverage expansion will drive a revaluation away from depressed medical device valuation.

At post $71.90Now $84.53+17.6% since postedas of Sep 8, 4:30 PM ET
1d+0.3%
3d+0.3%
1w+0.6%
1m+0.8%
3m+25.0%
6m—
1y—
original post →

End of results.